GlassScriptPhysician profile
Howard L Reeves
NPI 1639245350
$22,663.57
in general payments reported to CMS, 2019-2025
23 companies · $5,622 in 2025
The $5,622 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $167 · 2021: $299 · 2022: $4,863 · 2023: $5,610 · 2024: $5,421 · 2025: $5,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $2,399 · Travel and Lodging: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $13,933.33 |
| Food and Beverage | $2,398.67 |
| Travel and Lodging | $321.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18,137.87 | 2021-2025 | Venacure 1470 Pro |
| Endologix LLC | $1,304.03 | 2019-2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Silk Road Medical, INC. | $1,068.56 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $940.40 | 2019-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $281.22 | 2021-2024 | Endurant Iis, Closurefast |
| Inari Medical, INC. | $138.86 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lemaitre Vascular, INC. | $133.16 | 2019-2025 | Trivex System, Anastoclip Gc 8cm (Medium), Restoreflow |
| Shockwave Medical, INC | $99.17 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biocompatibles, INC. | $90.90 | 2019 | |
| Bard Peripheral Vascular, INC. | $70.46 | 2019-2021 | |
| Cook Medical LLC | $63.08 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $55.63 | 2019 | |
| Venclose INC. | $45.88 | 2020 | |
| Medtronic Vascular, INC. | $40.82 | 2019-2020 | |
| Ethicon US, LLC | $39.51 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $36.36 | 2019-2020 | |
| Boston Scientific Corporation | $31.49 | 2021-2022 | |
| Smith+Nephew, INC. | $25.86 | 2019 | |
| Cardiovascular Systems INC. | $14.77 | 2019 | |
| Convatec INC. | $13.31 | 2019 | |
| Terumo Medical Corporation | $13.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.43 | 2020 | |
| Intact Vascular, INC. | $7.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.